Caribou Biosciences(CRBU)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRBU Caribou Biosciences

交易中 12-15 10:45:50 EST

1.76

-0.03

-1.96%

最高1.85	最低1.72	成交量38.55万
今开1.84	昨收1.79	日振幅7.26%
总市值1.64亿	流通市值1.48亿	总股本9,347万
成交额67.63万	换手率0.46%	流通股本8,406万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRBU","market":"US","secType":"STK","nameCN":"Caribou Biosciences","latestPrice":1.755,"timestamp":1765813542836,"preClose":1.79,"halted":0,"volume":385473,"delay":0,"floatShares":84057626,"shares":93468038,"eps":-1.697865,"marketStatus":"交易中","change":-0.035,"latestTime":"12-15 10:45:50 EST","open":1.84,"high":1.85,"low":1.72,"amount":676250.5871781,"amplitude":0.072626,"askPrice":1.76,"askSize":1600,"bidPrice":1.75,"bidSize":3500,"shortable":3,"etf":0,"ttmEps":-1.697865,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"listingDate":1627012800000,"exchange":"NASDAQ","adjPreClose":1.79,"preHourTrading":{"tag":"盘前","latestPrice":1.85,"preClose":1.79,"latestTime":"09:25 EST","volume":2469,"amount":4512.6431489999995,"timestamp":1765808732803},"postHourTrading":{"tag":"盘后","latestPrice":1.8192,"preClose":1.79,"latestTime":"19:57 EST","volume":8727,"amount":15643.5696,"timestamp":1765587442308},"volumeRatio":2.033697,"impliedVol":1.4426,"impliedVolPercentile":0.68},"requestUrl":"/m/hq/s/CRBU/tweets","defaultTab":"tweets","newsList":[{"id":"1130051774","title":"Caribou Biosciences第三季度许可与合作收入为219.8万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130051774","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130051774?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:30","pubTimestamp":1763573405,"startTime":"0","endTime":"0","summary":"11月12日 - Caribou Biosciences第三季度净收入为-2754.8万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CRBU"],"gpt_icon":0},{"id":"2581779056","title":"Caribou Biosciences报告了关于同种异体CAR T疗法的临床数据，而Kyverna Therapeutics则推进了自身免疫项目Caribou Biosciences Reports Clinical Data on Allogeneic CAR T Therapies While Kyverna Therapeutics Advances Autoimmune Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2581779056","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581779056?lang=zh_cn&edition=full","pubTime":"2025-11-05 16:03","pubTimestamp":1762329780,"startTime":"0","endTime":"0","summary":"Caribou presented findings from trials involving its allogeneic CAR T therapies, which use donor-derived cells rather than a patient’s own cells. These therapies were tested in two separate cancer indications, though specific details regarding efficacy or safety outcomes were not disclosed in the report.Caribou公布了其同种异体CAR T疗法的试验结果，该疗法使用捐赠者来源的细胞而非患者自身的细胞。Meanwhile, Kyverna announced plans to move forward with its CAR T program aimed at treating autoimmune conditions. This marks a shift from the traditional focus of CAR T therapy on oncology and represents an effort to expand the technology’s applications into other therapeutic areas. Both companies continue to explore innovative approaches within this rapidly evolving sector of biotechnology..同时，Kyverna 宣布计划推进其旨在治疗自身免疫性疾病的 CAR T 项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110516052697554e2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110516052697554e2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4230","BK4139","BK4007","BK4022","LENZ","BK4539","CAR","KYTX"],"gpt_icon":0},{"id":"1149487787","title":"Caribou推出“今日汽车再融资利率”，开创每日利率资源带来超高透明度","url":"https://stock-news.laohu8.com/highlight/detail?id=1149487787","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149487787?lang=zh_cn&edition=full","pubTime":"2025-11-03 21:47","pubTimestamp":1762177630,"startTime":"0","endTime":"0","summary":"Caribou推出“今日汽车再融资利率”，这是首个每日利率资源，为借款人提供了前所未有的透明度，展现了贷款机构实际提供的利率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBU","BK4139","BK4539"],"gpt_icon":0},{"id":"1120112545","title":"Caribou Biosciences Inc - 预计截至2025年9月30日的现金和可交易证券为1.592亿美元 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1120112545","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120112545?lang=zh_cn&edition=full","pubTime":"2025-11-03 20:09","pubTimestamp":1762171749,"startTime":"0","endTime":"0","summary":"Caribou Biosciences Inc - 预计截至2025年9月30日的现金和可交易证券为1.592亿美元 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRBU","BK4539"],"gpt_icon":0},{"id":"1151285983","title":"Caribou Biosciences推荐扩展4.5亿细胞剂量；剂量扩展将在年底前启动，数据预计于2026年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1151285983","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151285983?lang=zh_cn&edition=full","pubTime":"2025-11-03 20:02","pubTimestamp":1762171334,"startTime":"0","endTime":"0","summary":"Caribou Biosciences推荐扩展4.5亿细胞剂量；剂量扩展将在年底前启动，数据预计于2026年公布","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","CRBU"],"gpt_icon":0},{"id":"1196909115","title":"Caribou Biosciences公布CB-011在多发性骨髓瘤Cammouflage I期试验中的积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1196909115","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196909115?lang=zh_cn&edition=full","pubTime":"2025-11-03 20:01","pubTimestamp":1762171292,"startTime":"0","endTime":"0","summary":"Caribou Biosciences公布CB-011在多发性骨髓瘤Cammouflage I期试验中的积极数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBU","BK4539","BK4139"],"gpt_icon":0},{"id":"1155001544","title":"Caribou Biosciences公布Antler I期试验的积极数据，证实Vispa-Cel (CB-010)的疗效和持久性，与自体CAR-T细胞疗法相媲美","url":"https://stock-news.laohu8.com/highlight/detail?id=1155001544","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155001544?lang=zh_cn&edition=full","pubTime":"2025-11-03 20:01","pubTimestamp":1762171278,"startTime":"0","endTime":"0","summary":"Caribou Biosciences公布Antler I期试验的积极数据，证实Vispa-Cel (CB-010)这款全源性CAR-T细胞疗法的疗效和持久性，与自体CAR-T细胞疗法相当。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBU","BK4539","BK4139"],"gpt_icon":0},{"id":"2577330336","title":"Caribou Biosciences, Inc.盘中异动 快速拉升5.32%报2.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577330336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577330336?lang=zh_cn&edition=full","pubTime":"2025-10-22 00:01","pubTimestamp":1761062471,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日00时01分，Caribou Biosciences, Inc.股票出现波动，股价大幅拉升5.32%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Minerva Neurosciences, Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Ibio, Inc.涨幅较大，Minerva Neurosciences, Inc、Ibio, Inc.、Rani Therapeutics Holdings, Inc.较为活跃，换手率分别为1877.33%、244.35%、145.90%，振幅较大的相关个股有Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.，振幅分别为215.34%、100.00%、47.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102200011294d61c6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102200011294d61c6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","CRBU"],"gpt_icon":0},{"id":"2568976282","title":"Caribou Biosciences, Inc.盘中异动 下午盘急速下挫5.06%报1.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568976282","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568976282?lang=zh_cn&edition=full","pubTime":"2025-09-20 02:31","pubTimestamp":1758306710,"startTime":"0","endTime":"0","summary":"北京时间2025年09月20日02时31分，Caribou Biosciences, Inc.股票出现异动，股价急速下挫5.06%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Adverum Biotechnologies, Inc.涨幅较大，Clearmind Medicine Inc.、Adaptimmune Therapeutics Plc、Aptevo Therapeutics Inc.较为活跃，换手率分别为675.49%、183.81%、165.75%，振幅较大的相关个股有Adaptimmune Therapeutics Plc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为65.63%、59.00%、43.54%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920023151953911ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920023151953911ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","CRBU"],"gpt_icon":0},{"id":"2557231626","title":"Caribou Biosciences, Inc.盘中异动 股价大跌5.00%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557231626","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557231626?lang=zh_cn&edition=full","pubTime":"2025-08-06 02:43","pubTimestamp":1754419432,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日02时43分，Caribou Biosciences, Inc.股票出现波动，股价大幅跳水5.00%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为3.99%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats  生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA  来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806024352a4771290&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806024352a4771290&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4539","BK4139"],"gpt_icon":0},{"id":"2557333388","title":"Caribou Biosciences, Inc.盘中异动 快速拉升5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557333388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557333388?lang=zh_cn&edition=full","pubTime":"2025-08-04 23:37","pubTimestamp":1754321839,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日23时37分，Caribou Biosciences, Inc.股票出现异动，股价快速上涨5.38%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.10%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd.、凯信远达涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5407.40%、1374.78%、563.98%，振幅较大的相关个股有凯信远达、Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为92.95%、84.21%、46.43%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804233720a474bd1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804233720a474bd1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4139","BK4539"],"gpt_icon":0},{"id":"2556516837","title":"Caribou Biosciences, Inc.盘中异动 快速上涨5.12%报2.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556516837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556516837?lang=zh_cn&edition=full","pubTime":"2025-08-01 00:30","pubTimestamp":1753979410,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日00时30分，Caribou Biosciences, Inc.股票出现异动，股价急速拉升5.12%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为2.92%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats  生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA  来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080100301094c6b5c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080100301094c6b5c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"gpt_icon":0},{"id":"2555042748","title":"Caribou Biosciences, Inc.盘中异动 早盘急速上涨5.61%报2.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555042748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555042748?lang=zh_cn&edition=full","pubTime":"2025-07-30 21:32","pubTimestamp":1753882363,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日21时32分，Caribou Biosciences, Inc.股票出现波动，股价大幅上涨5.61%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats  生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA  来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730213243a46bb4e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730213243a46bb4e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"gpt_icon":0},{"id":"2554124770","title":"Caribou Biosciences, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554124770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554124770?lang=zh_cn&edition=full","pubTime":"2025-07-28 22:48","pubTimestamp":1753714083,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日22时48分，Caribou Biosciences, Inc.股票出现异动，股价急速下挫5.04%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃，换手率分别为375.44%、190.04%、116.65%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为106.96%、82.93%、75.48%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822480394bf8b2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822480394bf8b2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4139","BK4539"],"gpt_icon":0},{"id":"2552327480","title":"Caribou Biosciences, Inc.盘中异动 早盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552327480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552327480?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:32","pubTimestamp":1752762730,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时32分，Caribou Biosciences, Inc.股票出现异动，股价大幅拉升5.19%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Marker Therapeutics, Inc.、Immuron Limited较为活跃，换手率分别为854.25%、351.73%、187.76%，振幅较大的相关个股有Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为148.12%、81.11%、61.18%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717223210a6b0111a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717223210a6b0111a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"gpt_icon":0},{"id":"2551719452","title":"Caribou Biosciences, Inc.盘中异动 股价大跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551719452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551719452?lang=zh_cn&edition=full","pubTime":"2025-07-16 03:18","pubTimestamp":1752607082,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日03时18分，Caribou Biosciences, Inc.股票出现波动，股价急速下跌5.59%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.29%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Polyrizon Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3630.87%、2178.02%、1564.68%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.，振幅分别为444.11%、116.77%、75.50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071603180397a768b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071603180397a768b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4539","BK4139"],"gpt_icon":0},{"id":"2551187149","title":"Caribou Biosciences, Inc.盘中异动 早盘大幅拉升5.32%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551187149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551187149?lang=zh_cn&edition=full","pubTime":"2025-07-14 23:04","pubTimestamp":1752505447,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日23时04分，Caribou Biosciences, Inc.股票出现异动，股价快速拉升5.32%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.28%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.、Promis Neurosciences Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为1952.41%、976.03%、604.03%，振幅较大的相关个股有Promis Neurosciences Inc.、Dare Bioscience, Inc.、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为210.04%、172.16%、145.07%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071423040797a5d273&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071423040797a5d273&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBU","BK4539"],"gpt_icon":0},{"id":"2550595947","title":"Caribou Biosciences, Inc.盘中异动 大幅下挫5.46%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550595947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550595947?lang=zh_cn&edition=full","pubTime":"2025-07-11 21:47","pubTimestamp":1752241627,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日21时47分，Caribou Biosciences, Inc.股票出现异动，股价大幅下挫5.46%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.71%。其相关个股中，Seastar Medical Holding Corp C/Wts 28/10/2027 、Apollomics Inc C/Wts 01/04/2028 、Alterity Therapeutics Limited涨幅较大，Cel-Sci Corporation、Dare Bioscience, Inc.、Creative Medical Technology Holdings, Inc.较为活跃，换手率分别为135.26%、76.31%、24.31%，振幅较大的相关个股有Cel-Sci Corporation、Revelation Biosciences Inc C/Wts 10/01/2027 、Abvc Biopharma, Inc.，振幅分别为61.26%、25.22%、21.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711214708a6a4000e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711214708a6a4000e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"gpt_icon":0},{"id":"2549528981","title":"Caribou Biosciences, Inc.盘中异动 大幅拉升5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549528981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549528981?lang=zh_cn&edition=full","pubTime":"2025-07-08 21:41","pubTimestamp":1751982110,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时41分，Caribou Biosciences, Inc.股票出现异动，股价大幅上涨5.40%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats  生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA  来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708214150a69d502e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708214150a69d502e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4139","BK4539"],"gpt_icon":0},{"id":"2548818185","title":"Caribou Biosciences, Inc.盘中异动 大幅拉升5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548818185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548818185?lang=zh_cn&edition=full","pubTime":"2025-07-02 22:07","pubTimestamp":1751465225,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日22时07分，Caribou Biosciences, Inc.股票出现异动，股价快速拉升5.60%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。其相关个股中，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Nutriband Inc C/Wts 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Windtree Therapeutics, Inc.、Lixte Biotechnology Holdings, Inc.、Aditxt, Inc.较为活跃，换手率分别为1738.53%、448.57%、125.39%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Lixte Biotechnology Holdings, Inc.、Nutriband Inc C/Wts ，振幅分别为1145.92%、96.61%、94.35%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070222070595340664&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070222070595340664&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cariboubio.com","stockEarnings":[{"period":"1week","weight":-0.0579},{"period":"1month","weight":-0.208},{"period":"3month","weight":-0.0056},{"period":"6month","weight":0.6126},{"period":"1year","weight":-0.0773},{"period":"ytd","weight":0.1258}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Caribou Biosciences, Inc.于2011年10月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，致力于通过应用该公司的新型CRISPR平台、CRISPR混合RNA-DNA或chRDNA来开发下一代基因组编辑细胞疗法，从而改变患有毁灭性疾病的患者的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.042916},{"month":2,"riseRate":0.25,"avgChangeRate":-0.02917},{"month":3,"riseRate":0,"avgChangeRate":-0.194501},{"month":4,"riseRate":0,"avgChangeRate":-0.1865},{"month":5,"riseRate":0.75,"avgChangeRate":0.047596},{"month":6,"riseRate":0.25,"avgChangeRate":-0.156574},{"month":7,"riseRate":1,"avgChangeRate":0.553226},{"month":8,"riseRate":0.4,"avgChangeRate":0.113188},{"month":9,"riseRate":0.4,"avgChangeRate":-0.017718},{"month":10,"riseRate":0.2,"avgChangeRate":-0.070494},{"month":11,"riseRate":0.4,"avgChangeRate":0.066546},{"month":12,"riseRate":0,"avgChangeRate":-0.177775}],"exchange":"NASDAQ","name":"Caribou Biosciences","nameEN":"Caribou Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Caribou Biosciences(CRBU)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Caribou Biosciences(CRBU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Caribou Biosciences,CRBU,Caribou Biosciences股票,Caribou Biosciences股票老虎,Caribou Biosciences股票老虎国际,Caribou Biosciences行情,Caribou Biosciences股票行情,Caribou Biosciences股价,Caribou Biosciences股市,Caribou Biosciences股票价格,Caribou Biosciences股票交易,Caribou Biosciences股票购买,Caribou Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Caribou Biosciences(CRBU)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Caribou Biosciences(CRBU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}